anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Disclaimer

Component collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 41,127
Current window 31,921-31,950
Pages 1,371
Rows per page 30
Component: Disclaimerclear collectionreset all
18 30 60

Component

31,921-31,950 of 41,127

filter-aware
34
Includes governance principles and leadership team statistics as of September 30, 2023.Apollo Global Management | Investor Presentation Deck | 42 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
37
Includes detailed footnotes explaining specific adjustments like equity-based profit sharing and merger-related costs.Apollo Global Management | Investor Presentation Deck | 42 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
01
Slide 1
Arbutus Biopharma | Investor Presentation Deck | 26 slidesArbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Conference presentation Investor relations 1 hit
02
Arbutus Biopharma | Investor Presentation Deck | 26 slidesArbutus Biopharma | Investor Presentation Deck | 26 slides · Arbutus Biopharma
Conference presentation Investor relations 1 hit
02
argenx SE | Investor Presentation Deck | 25 slidesargenx SE | Investor Presentation Deck | 25 slides · argenx
Conference presentation Investor relations 1 hit
05
The slide highlights the two different delivery methods (IV vs Subcutaneous) for the same underlying treatment.argenx SE | Investor Presentation Deck | 25 slides · argenx
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
12
The slide uses a pyramid structure to represent market size, with larger patient populations at the base.argenx SE | Investor Presentation Deck | 25 slides · argenx
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
02
argenx SE | Investor Presentation Deck | 7 slidesargenx SE | Investor Presentation Deck | 7 slides · argenx
Conference presentation Investor relations 1 hit
06
The slide uses a pyramid layout to represent market segments by patient population size.argenx SE | Investor Presentation Deck | 7 slides · argenx
Conference presentation Investor relations Beat · Market SizeLoop · Cost Of Inaction1 hit
01
Slide 1
arm | Investor Presentation Deck | 8 slidesarm | Investor Presentation Deck | 8 slides · Arm
Conference presentation Investor relations 1 hit
08
Includes a footnote regarding a one-time $45m social security tax increase in Q4.arm | Investor Presentation Deck | 8 slides · Arm
Conference presentation Investor relations 1 hit
04
The slide uses a consistent 'before-after' visual style for each metric, highlighting the delta between FY22 and FY23.Asos | Results Presentation Deck | 69 slides · Asos
Conference presentation Investor relations Beat · Situation & Context1 hit
05
The slide uses a combination of a data table and a bar chart to illustrate the trade-off between volume and profitability.Asos | Results Presentation Deck | 69 slides · Asos
Conference presentation Investor relations Beat · Problem & Complication1 hit
06
The slide uses a color-coded table to contrast regional performance metrics.Asos | Results Presentation Deck | 69 slides · Asos
Conference presentation Investor relations Beat · Problem & Complication1 hit
02
AstraZeneca | Results Presentation Deck | 45 slidesAstraZeneca | Results Presentation Deck | 45 slides · AstraZeneca
Conference presentation Investor relations Beat · Attention1 hit
05
Includes a footer with definitions and guidance update.AstraZeneca | Results Presentation Deck | 45 slides · AstraZeneca
Conference presentation Investor relations Beat · NeedLoop · Logic Chain1 hit
17
Includes medical imaging and bar charts for clinical trial outcomes.AstraZeneca | Results Presentation Deck | 45 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
18
Includes waterfall plots for two patient cohorts and a trial design schematic.AstraZeneca | Results Presentation Deck | 45 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
20
Includes a navigation bar at the top indicating this is part of a larger presentation.AstraZeneca | Results Presentation Deck | 45 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
22
Slide includes a navigation bar at the top indicating current section is BioPharmaceuticals.AstraZeneca | Results Presentation Deck | 45 slides · AstraZeneca
Conference presentation Investor relations 1 hit
25
Includes a bar chart for UACR reduction and a mechanism-of-action/pipeline diagram for tozorakimab.AstraZeneca | Results Presentation Deck | 45 slides · AstraZeneca
Conference presentation Investor relations 1 hit
28
Includes revenue breakdown for Ultomiris, Soliris, Strensiq, and others; regional breakdown; and C5 franchise indication mix.AstraZeneca | Results Presentation Deck | 45 slides · AstraZeneca
Conference presentation Investor relations 1 hit
31
The slide uses a navigation bar at the top to indicate the current section is 'CEO Opening Remarks'.AstraZeneca | Results Presentation Deck | 45 slides · AstraZeneca
Conference presentation Investor relations Beat · Action1 hit
34
The slide uses color coding to distinguish between therapeutic areas: Oncology (dark purple), BioPharmaceuticals (light blue), and Rare Disease (magenta).AstraZeneca | Results Presentation Deck | 45 slides · AstraZeneca
Conference presentation Investor relations 1 hit
37
The slide uses a matrix-like structure to map patient risk profiles against treatment lines, highlighting specific drug trials (e.g., SERENA, CAPItello, CAMBRIA, DESTINY).AstraZeneca | Results Presentation Deck | 45 slides · AstraZeneca
Conference presentation Investor relations 1 hit
38
The chart tracks revenue performance across three categories over nine quarters.AstraZeneca | Results Presentation Deck | 45 slides · AstraZeneca
Conference presentation Investor relations 1 hit
39
Data presented in stacked bar charts with corresponding data tables below each chart.AstraZeneca | Results Presentation Deck | 45 slides · AstraZeneca
Conference presentation Investor relations 1 hit
40
Contains two charts: a stacked bar chart for product sales and a grouped bar chart for collaboration revenue.AstraZeneca | Results Presentation Deck | 45 slides · AstraZeneca
Conference presentation Investor relations 1 hit
41
Data presented in stacked bar charts with corresponding data tables below each chart.AstraZeneca | Results Presentation Deck | 45 slides · AstraZeneca
Conference presentation Investor relations 1 hit
42
CER = constant exchange rates; EM = Emerging Markets; ERoW = Established Rest of World.AstraZeneca | Results Presentation Deck | 45 slides · AstraZeneca
Conference presentation Investor relations 1 hit